Page 62 - CJO_F17_GLAUCOMA_SUPPLEMENT

C CLINICAL RESEARCH

Carbonic Anhydrase Inhibitors – Oral
acetazolamide 1955 250 mg Diamox (and generics) QID Tabs N/A
methazolamide 50mg (generics) TID Tabs N/A
Miotics
1, 2, 4% MIOCARPINE
(6 no longer (and generics) QID 15 mL BAK
pilocarpine available)
4% PILOPINE HS QD hs Gel 5 g tube BAK
Combination Anti-glaucoma Drugs
latanoprost / 2001 0.005% / 0.5% XALACOM QD (am) 2.5mL BAK
timolol
travoprost / 2003 0.004%/0.5% DUOTRAV PQ QD (am) 2.5, 5mL Polyquad,
timolol SofZia
brimonidine / 2006 0.2% / 0.5% COMBIGAN BID 5, 10mL BAK
timolol
dorzolamide / COSOPT (and generics) 5, 10mL BAK
timolol 1998 2% / 0.5% COSOPT PF BID 0.4mL x 30 vials PF
brinzolamide / 2008 1% / 0.5% AZARGA BID 5mL BAK
timolol
brinzolamide / 2014 1% / 0.2% SIMBRINZA BID Susp 10mL BAK
brimonidine

62 CANADIAN JOURNAL of OPTOMETRY | REVUE CANADIENNE D’OPTOMÉTRIE VOL. 79 SUPPLEMENT 1, 2017